Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Technology in Cancer Research & Treatment
|
April 9, 2024
Breast Cancer Prediction Based on Multiple Machine Learning Algorithms
Sheng Zhou, Chujiao Hu, Shanshan Wei, et al.
International Immunopharmacology
|
June 22, 2023
Reconsideration of interferon treatment for viral diseases: Lessons from SARS, MERS, and COVID-19
Dan Ma, Ximin Wang, Min Li, et al.
Frontiers in Pharmacology
|
September 26, 2022
Discovery of novel <i>IDH1</i>-R132C inhibitors through structure-based virtual screening
Chujiao Hu, Zhirui Zeng, Dan Ma, et al.
Frontiers in Immunology
|
October 3, 2022
A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy
Runsang Pan, Feng Pan, Zhirui Zeng, et al.
Communications Biology
|
February 16, 2026
CRISPR-Cas9 screening identifies ATOX1-driven cisplatin resistance mechanisms in liver cancer and evaluates targeted inhibitor efficacy
Chujiao Hu, Huading Tai, Renguang Zhu, et al.
Frontiers in Pharmacology
|
December 4, 2023
Integrated investigation and experimental validation of PPARG as an oncogenic driver: implications for prognostic assessment and therapeutic targeting in hepatocellular carcinoma
Yunsheng Ran, Chujiao Hu, Junzhao Wan, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 15, 2019
Licochalcone A suppresses the proliferation of sarcoma HT-1080 cells, as a selective R132C mutant IDH1 inhibitor
Chujiao Hu, Yu Zuo, Jingqiu Liu, et al.
Frontiers in Immunology
|
September 26, 2022
A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy
Zhirui Zeng, Chujiao Hu, Wanyuan Ruan, et al.
Aging
|
March 18, 2024
Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy
Wenpeng Cao, Jinzhi Lan, Chujiao Hu, et al.
Cell Communication and Signaling : CCS
|
August 28, 2025
Whole-gene CRISPR/cas9 library screen revealed targeting STAT6 increased the sensitivity of liver cancer to celecoxib via inhibiting arachidonic acid shunting
Chujiao Hu, Zhirui Zeng, Xin Bao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Technology in Cancer Research & Treatment
|
April 9, 2024
Breast Cancer Prediction Based on Multiple Machine Learning Algorithms
Sheng Zhou, Chujiao Hu, Shanshan Wei, et al.
International Immunopharmacology
|
June 22, 2023
Reconsideration of interferon treatment for viral diseases: Lessons from SARS, MERS, and COVID-19
Dan Ma, Ximin Wang, Min Li, et al.
Frontiers in Pharmacology
|
September 26, 2022
Discovery of novel <i>IDH1</i>-R132C inhibitors through structure-based virtual screening
Chujiao Hu, Zhirui Zeng, Dan Ma, et al.
Frontiers in Immunology
|
October 3, 2022
A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy
Runsang Pan, Feng Pan, Zhirui Zeng, et al.
Communications Biology
|
February 16, 2026
CRISPR-Cas9 screening identifies ATOX1-driven cisplatin resistance mechanisms in liver cancer and evaluates targeted inhibitor efficacy
Chujiao Hu, Huading Tai, Renguang Zhu, et al.
Frontiers in Pharmacology
|
December 4, 2023
Integrated investigation and experimental validation of PPARG as an oncogenic driver: implications for prognostic assessment and therapeutic targeting in hepatocellular carcinoma
Yunsheng Ran, Chujiao Hu, Junzhao Wan, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 15, 2019
Licochalcone A suppresses the proliferation of sarcoma HT-1080 cells, as a selective R132C mutant IDH1 inhibitor
Chujiao Hu, Yu Zuo, Jingqiu Liu, et al.
Frontiers in Immunology
|
September 26, 2022
A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy
Zhirui Zeng, Chujiao Hu, Wanyuan Ruan, et al.
Aging
|
March 18, 2024
Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy
Wenpeng Cao, Jinzhi Lan, Chujiao Hu, et al.
Cell Communication and Signaling : CCS
|
August 28, 2025
Whole-gene CRISPR/cas9 library screen revealed targeting STAT6 increased the sensitivity of liver cancer to celecoxib via inhibiting arachidonic acid shunting
Chujiao Hu, Zhirui Zeng, Xin Bao, et al.
Page
of 2